SCHEMBL2511075

SCHEMBL2511075

CCc1ccc2nc(C)c(C(=O)O)c(N)c2c1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HSD17B10 Q99714 3/20 0.39
TP53 P04637 2/20 0.39
METAP2 P50579 1/20 0.37
DHFR P00374 2/20 0.36
ALDH1A1 P00352 5/20 0.36
PDE3A Q14432 2/20 0.36
GABRP O00591 2/20 0.36
GABRD O14764 2/20 0.36
GABRA1 P14867 2/20 0.36
GABRB1 P18505 2/20 0.36
GABRG2 P18507 2/20 0.36
GABRB3 P28472 2/20 0.36
GABRA5 P31644 2/20 0.36
GABRA3 P34903 2/20 0.36
GABRA2 P47869 2/20 0.36
GABRB2 P47870 2/20 0.36
GABRA4 P48169 2/20 0.36
GABRE P78334 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2517588 0.87 TARBP2 (0.36) MEN1KMT2AHSD17B10TP53DHFR
SCHEMBL2513020 0.86 TP53 (0.36) MEN1KMT2AHSD17B10TP53DHFR
SCHEMBL2511949 0.85 TP53 (0.41) MEN1KMT2AHSD17B10TP53GABRP
SCHEMBL2512534 0.84 KMT2A (0.36) MEN1KMT2AHSD17B10TP53DHFR
SCHEMBL2514175 0.83 TP53 (0.34) MEN1KMT2AHSD17B10TP53DHFR
SCHEMBL2514017 0.83 TP53 (0.37) MEN1KMT2AHSD17B10TP53DHFR
SCHEMBL2516707 0.83 KMT2A (0.35) MEN1KMT2AHSD17B10TP53METAP2
SCHEMBL2514942 0.83 GRM1 (0.36) MEN1KMT2AHSD17B10TP53DHFR
SCHEMBL2511926 0.82 GRM1 (0.35) MEN1KMT2AHSD17B10TP53DHFR
SCHEMBL2511946 0.82 GRM1 (0.35) MEN1KMT2AHSD17B10TP53DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8592592-B2 Sweet flavor modifier SENOMYX, INC. (US) 2013-11-26 US disclosed
US-20110245353-A1 SWEET FLAVOR MODIFIER SENOMYS, INC. (US) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245353-A1 SWEET FLAVOR MODIFIER TAS2R5, TAS2R10, TAS2R50 MEN1 784/4885KMT2A 1673/4885HSD17B10 1094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.